GPEx (SA) Revenue and Competitors

Unley, SA Australia

Location

N/A

Total Funding

Education

Industry

Estimated Revenue & Valuation

  • GPEx (SA)'s estimated annual revenue is currently $9.6M per year.(i)
  • GPEx (SA)'s estimated revenue per employee is $162,000

Employee Data

  • GPEx (SA) has 59 Employees.(i)
  • GPEx (SA) grew their employee count by -16% last year.

GPEx (SA)'s People

NameTitleEmail/Phone
1
Executive ManagerReveal Email/Phone
2
Education Delivery Project CoordinatorReveal Email/Phone
3
Lead AnalystReveal Email/Phone
4
Placements ContractorReveal Email/Phone
5
Senior GP Consultant/Medical EducatorReveal Email/Phone
6
Lead Medical Educator - Professional Development ProgramsReveal Email/Phone
7
GP Workforce Planning and Prioritisation (WPP) & Transition ManagerReveal Email/Phone
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingValuation
#1
$79M35136%N/AN/A
#2
$10.5M6520%N/AN/A
#3
$58M2936%N/AN/A
#4
$29.5M1498%N/AN/A
#5
$21.6M12010%N/AN/A
#6
$9.6M59-16%N/AN/A
#7
$39.6M2006%N/AN/A
#8
$30.7M1557%N/AN/A
#9
$18.5M1031%N/AN/A
Add Company

What Is GPEx (SA)?

GPEx is the South Australian Training Organisation which delivers general practice training to doctors selected to specialise in General Practice in Australia. If you want the opportunity to become an exceptional doctor, GPEx should be your first choice.

keywords:N/A

N/A

Total Funding

59

Number of Employees

$9.6M

Revenue (est)

-16%

Employee Growth %

N/A

Valuation

N/A

Accelerator

GPEx (SA) News

2022-04-17 - Cell Line Development Market Key Findings, Future Insights, Market ...

... MRFR report are Selexis SA (Switzerland), Lonza Group AG (Switzerland), ... Backed by the company's GPEx expression platform within a...

2022-03-22 - Doctors want to stay in hospitals', says trainer

On one hand, chairman of GPEx Doctor Tony Sherbon said general ... the committee chair Janet Rice of The Greens, and SA-Best Senator Rex...

Company NameRevenueNumber of EmployeesEmployee GrowthTotal Funding
#1
$35.7M1015%N/A
#2
$28.6M1066%N/A
#3
$32.3M1406%N/A
#4
$127.7M4175%N/A